Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PASITHEA THERAPEUTICS CORP.

(KTTA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Pasithea Therapeutics : Partners With Evotec for Drug Development Project

10/11/2021 | 10:53am EST


ę MT Newswires 2021
All news about PASITHEA THERAPEUTICS CORP.
2021Wall Street Set for Small Gains Ahead of Christmas Break
MT
2021Pasithea Therapeutics Opens Second Ketamine Therapy Clinic in the United Kingdom
AQ
2021Pasithea Clinics Opens Second Ketamine Therapy Clinic in the United Kingdom
CI
2021PASITHEA THERAPEUTICS CORP. : Change in Directors or Principal Officers (form 8-K)
AQ
2021PASITHEA THERAPEUTICS CORP.(NASDAQCM : KTTA) added to S&P TMI Index
CI
2021Pasithea Therapeutics Expands its Mobile Clinics into Florida and Nevada
AQ
2021Pasithea Therapeutics Expands its Mobile Clinics into Florida and Nevada
CI
2021PASITHEA THERAPEUTICS : Announces Pricing of a $30.4 Million Private Placement Priced At a..
PU
2021Pasithea Therapeutics Corp. Announces Closing of $30.4 Million Private Placement Priced..
GL
2021PASITHEA THERAPEUTICS CORP. : Entry into a Material Definitive Agreement, Unregistered Sal..
AQ
More news
Financials (USD)
Sales 2021 0,10 M - -
Net income 2021 - - -
Net cash 2021 0,24 M - -
P/E ratio 2021 -
Yield 2021 -
Capitalization 30,2 M 30,2 M -
EV / Sales 2021 300x
EV / Sales 2022 6,40x
Nbr of Employees 2
Free-Float 64,7%
Chart PASITHEA THERAPEUTICS CORP.
Duration : Period :
Pasithea Therapeutics Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PASITHEA THERAPEUTICS CORP.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 1,38 $
Average target price 3,99 $
Spread / Average Target 189%
Managers and Directors
Tiago Reis Marques Chief Executive Officer & Director
Stanley M. Gloss Chief Financial Officer
Israel Maxx Abramowitz Co-Chief Operating Officer & Director
Yassine Bendiabdallah Co-Chief Operating Officer & Director
Craig Auringer Director
Sector and Competitors
1st jan.Capi. (M$)
PASITHEA THERAPEUTICS CORP.-22.03%30
MODERNA, INC.-19.39%83 008
LONZA GROUP AG-15.15%53 950
IQVIA HOLDINGS INC.-12.33%47 252
SEAGEN INC.-11.33%25 068
ICON PUBLIC LIMITED COMPANY-13.98%21 684